PhiOanh Leia NghiemPhu
@leia-n-md.bsky.social
Neuro-Oncologist, Neurologist, NF/SWN-ologist, VC Academic Affairs, IRB Chair | UCLA Neurology/Neuro-Oncology
Also for rare diseases, what pharma would take a chance on clinical trials to help a few thousand patients or less. They want to see academia performs at least early pilot trials first.
April 8, 2025 at 5:07 PM
Also for rare diseases, what pharma would take a chance on clinical trials to help a few thousand patients or less. They want to see academia performs at least early pilot trials first.